NIH Study on Topical Steroid Withdrawal Faces Setbacks Amid Federal Changes
On May 23, 2023, Kelly Barta arrived at the National Institutes of Health to address…
Newswire
Federal Cuts Threaten U.S. Food Safety Amid Rising Health Risks
The recent infant botulism outbreak linked to ByHeart formula, which affected dozens of infants, underscores…
Novartis and US Government Finalize Agreement to Lower Drug Prices
Novartis has finalized an agreement with the US government aimed at reducing the prices of…
Cytokinetics set to battle Bristol Myers as FDA approves heart drug
The FDA has granted approval for Cytokinetics’ Myqorzo, marking a significant milestone as the company’s…
Biopharma Stocks Surge as Market Rebounds in 2025
As 2025 concludes, the biopharmaceutical sector is witnessing a significant resurgence, with existing public companies…
Autophagy-Driven Mitochondrial Inheritance Shapes CD8+ T Cell Fate, Division
Researchers at the Max Delbrück Center and the University of Oxford have discovered that autophagy,…
Francis Collins Advocates for Vaccine Acceptance Among Religious Communities
In a recent interview on the “First Opinion Podcast,” renowned geneticist Francis Collins emphasized the…
Nine More MFN Deals Highlight Shift in Pharma Landscape
In a significant development, nine new Most Favored Nation (MFN) deals have been announced, underscoring…
FDA Approves Jascayd for Progressive Pulmonary Fibrosis Treatment
The U.S. Food and Drug Administration (FDA) has granted approval for Jascayd (nerandomilast) tablets, marking…
FDA Approves Cytokinetics’ Heart Drug, Giving It an Edge Over BMS Rival
Cytokinetics has achieved a significant milestone with the recent FDA approval of its heart drug,…